In a study published in the journal Science, it was revealed that a pan-variant and ultra-potent neutralizing antibody named ′S2X324′ was found to be largely unaffected by any of the Omicron variants. The researchers suggested that combining this antibody with others in a vaccine can help reduce the chances of the virus becoming antibody-treatment resistant.

Based on the findings of the study, the research team explained that mutations in two of the main antibody targets in the virus resulted in a marked reduction in the antibody-neutralizing ability against these variants, especially in people who have not received booster doses. As a result, an increase in the number of reinfections was observed, but the cases were found to be milder in comparison to infections of immunologically naA-ve individuals. 

(Source: https://www.daijiworld.com/news/newsDisplay?newsID=1014932 )